BladderBRIDGister: Translational Real-World-Registry with Clinical and Molecularpathological Data

Recruiting

• Conditions: C67.8; Overlapping lesion of bladder

• Registration Number: DRKS00027128
• Lead Sponsor: ceoGEN GmbH

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2022-01-17
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 10000

Inclusion Criteria

patients with suspected bladder cancer
Patients without evidence of urothelial carcinoma who undergo cystoscopy due to benign pathology (stone therapy, deobstructive therapy of BPS, etc.) and thus act as a healthy comparison group

Exclusion Criteria

pregnancy
Lack of reconnaissance ability

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
progression free survival<br>Sensitivity

Secondary Outcome Measures

Name	Time	Method
RFS, DSS, QoL<br>Specificity, PPV, NPV, accuracy, AUC of diagnostic performance